• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2018 Fiscal Year Final Research Report

Regulatory mechanisms of miRNA biogenesis which is involved in tumorigenesis for approach to cancer therapy

Research Project

  • PDF
Project/Area Number 17K15601
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field General medical chemistry
Research InstitutionKochi University

Principal Investigator

HIGUCHI Takuma  高知大学, 教育研究部医療学系基礎医学部門, 助教 (10754567)

Research Collaborator SAKAMOTO Shuji  高知大学, 教育研究部医療学系基礎医学部門, 准教授
Project Period (FY) 2017-04-01 – 2019-03-31
KeywordsRNA結合タンパク質 / miRNA / NF90 / がん / RNA二次構造
Outline of Final Research Achievements

(1) Nuclear Factor 90 (NF90), which is double stranded RNA binding protein, and NF45 form a heterodimer complex (NF90-NF45). In cancer tissues, NF90-NF45 is known to bind to primary miRNAs (pri-miRNAs), resulting in an inhibition of anti-oncogenic miRNA biogenesis. However, a common characteristic of pri-miRNA for NF90 binding motif is still unclear. In this study, we found that NF90 preferentially binds to pri-miRNAs that have a structure of straight stem with few mismatches.
(2) We demonstrated that miR-7, an anti-oncogenic miRNA, regulates the expression of NF90. Taken together with our previously findings that NF90-NF45 suppresses miR-7 biogenesis, it suggests that the level of NF90 is increased by a negative feedback loop between NF90 and miR-7 in tumor tissues under physiological conditions.
Based on (1) and (2), we would expect to be applied oligo RNAs, which have a NF90 binding motif, and miR-7 to cancer therapy.

Free Research Field

分子生物学

Academic Significance and Societal Importance of the Research Achievements

NF90とNF45の複合体はがん部で高く発現しており、がん抑制作用を有する複数のmiRNAの生合成を阻害している。本研究の成果より、NF90の結合するpri-miRNAの構造が同定できたため、その情報を元に、内在性pri-miRNAよりもNF90-NF45に対して結合性の高いオリゴヌクレオチド (デコイRNA)を作製することが可能となった。デコイRNAはNF90-NF45のmiRNA生合成阻害機能を抑える効果が期待できるため、新規のがん治療法開発の礎となることが想定される。

URL: 

Published: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi